IDXX · Idexx Laboratories Inc /De · Financials
$518.39
+0.64 (+0.12%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$40.91B
Shares
78.78M
Volume · Oct 2
288.82K
Avg daily vol (3M)
558.85K
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$4.3B
+10.4%
FY2025
Net Income
$1.06B
+19.3%
FY2025
Gross Margin
61.8%
+0.8pp
FY2025
Operating Margin
31.6%
+2.6pp
FY2025
Diluted EPS
$13.08
+22.6%
FY2025
Operating Cash Flow
$1.18B
+27.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $4.55B | $4.3B | $3.9B | $3.66B | $3.37B | $3.22BG | $2.71B | $2.41B | $2.21B | $1.97B | $1.78B | $1.6B | $1.49B | $1.38B | $1.29B | $1.22B | $1.1B | $1.03B | $1.02B | |
| — | $16.5M | $15.8M | $13.9M | $20.7M | $20.3M | $20.8M | $17.5M | $20.8M | $12.2M | — | — | — | — | — | — | — | — | — | — | |
| — | $1.71B | $1.64B | $1.52B | $1.47B | $1.36B | $1.33B | $1.14B | $1.04B | $971.7M | $871.68M | $799.99M | $711.62M | $669.69M | $620.94M | $594.19M | $572.18M | $524.77M | $505.35M | $494.26M | |
| — | $2.84B | $2.66B | $2.38B | $2.19B | $2B | $1.89B | $1.57B | $1.37B | $1.24B | $1.1B | $975.44M | $890.27M | $816.12M | $756.12M | $699.15M | $646.51M | $578.62M | $526.28M | $529.77M | |
| — | — | 61.8% | 61.04% | 59.82% | 59.52% | 58.76% | 58.04% | 56.73% | 56.1% | 55.73% | 54.94% | 55.58% | 54.93% | 54.91% | 54.06% | 53.05% | 52.44% | 51.01% | 51.73% | |
| — | $261.47M | $251.21M | $219.79M | $190.95M | $254.82M | $161.01M | $141.25M | $133.19M | $117.86M | $109.18M | $101.12M | $99.68M | $98.26M | $88M | $82.01M | $76.04M | $68.6M | $65.12M | $70.67M | |
| — | $672.74M | $643.55M | $588.51M | $566.07M | $524.51M | $486.74M | $434.44M | $418.19M | $387.41M | $354.29M | $317.06M | $299.96M | $283.71M | $243.49M | $216.96M | $204.85M | $179.63M | $167.75M | $169.96M | |
| — | $450.48M | $404.79M | $442.29M | $335.83M | $326.25M | $309.66M | $300.83M | $261.32M | $244.94M | $220.88M | $207.02M | $182.51M | $173.89M | $157.86M | $137.61M | $129.39M | $126.52M | $117.44M | $116.68M | |
| — | — | $20.2M | $17.1M | $13.8M | $15M | $12.1M | $9.8M | $9.4M | $8.9M | $9M | $9.5M | $10.4M | $9.8M | $9.7M | $9.8M | $8.7M | $9M | — | — | |
| — | $154.08M | $145.18M | $129.94M | $114.91M | $111.9M | $104.6M | $96M | $88.01M | $83.18M | $83.14M | $78.22M | $68.96M | $58.89M | $54.6M | $52.41M | $48.2M | $45.96M | $49.77M | $47.98M | |
| — | $1.38B | $1.3B | $1.25B | $1.09B | $1.11B | — | — | — | $750.21M | — | — | — | — | — | — | — | — | — | — | |
| — | $1.46B | $1.36B | $1.13B | $1.1B | $898.77M | $932.03M | $694.52M | $552.85M | $491.34M | $413.03M | $350.24M | $299.91M | $260.26M | $266.76M | $262.56M | $236.23M | $203.88M | $175.97M | $172.46M | |
| — | — | 31.6% | 28.95% | 29.97% | 26.69% | 28.99% | 25.66% | 22.97% | 22.2% | 20.98% | 19.73% | 18.72% | 17.52% | 19.37% | 20.3% | 19.38% | 18.48% | 17.06% | 16.84% | |
| — | $1.61B | $1.51B | $1.26B | $1.21B | $1.01B | $1.04B | $790.52M | $640.86M | $574.51M | $496.17M | $428.46M | $368.87M | $319.14M | $321.36M | $314.97M | $284.43M | $249.84M | $225.74M | $220.44M | |
| — | $37.79M | $38.85M | $31.21M | $41.58M | $39.86M | $29.81M | $33.13M | $31.06M | $34.74M | $37.23M | $32.05M | $29.24M | $15.43M | $5.39M | $3.85M | $3.55M | $2.42M | $1.92M | $4.59M | |
| — | $1.42B | $1.32B | $1.11B | $1.06B | $859.97M | $902.65M | $661.99M | $522.22M | $457.74M | $381.06M | $321.85M | $273.14M | $246.56M | $263.26M | $260.62M | $234.42M | $202.13M | $174.54M | $170.19M | |
| — | $284.76M | $264.73M | $221.96M | $216.13M | $180.88M | $157.81M | $79.85M | $94.43M | $80.7M | $117.79M | $99.79M | $81.01M | $64.6M | $75.47M | $82.33M | $72.67M | $60.81M | $52.3M | $54.02M | |
| — | $1.14B | $1.06B | $887.87M | $845.04M | $679.09M | $744.85M | $581.78M | $427.72M | $377.03M | $263.14M | $222.05M | $192.08M | $181.91M | $187.8M | $178.27M | $161.79M | $141.28M | $122.23M | $116.17M | |
| — | — | 24.62% | 22.78% | 23.08% | 20.17% | 23.17% | 21.49% | 17.77% | 17.04% | 13.36% | 12.51% | 11.99% | 12.24% | 13.64% | 13.78% | 13.28% | 12.8% | 11.85% | 11.34% | |
| — | — | — | — | $0 | $0 | -$1000 | $355K | $72K | $16K | $125K | $9000 | $57K | $45K | -$6000 | $20K | -$32K | $36K | $10K | — | |
| — | $1.15B | $1.08B | $865.43M | $851.63M | $654.78M | $744.98M | $574.34M | $423.33M | $371.71M | $269.73M | $221.26M | $157.88M | $160.21M | $185.47M | $178.78M | $163.76M | $144.41M | — | — | |
| USD/shares | — | $14.32 | $13.17 | $10.77 | $10.17 | $8.12 | $8.74 | $6.82 | $4.97 | $4.34 | $3.00 | $2.47 | $2.07 | $1.82 | $1.77 | $3.24 | $2.85 | $2.45 | $2.08 | $1.94 |
| USD/shares | $14.69 – $14.94 | $14.23 | $13.08 | $10.67G | $10.06 | $8.03 | $8.60G | $6.71 | $4.89 | $4.26 | $2.94 | $2.44 | $2.05 | $1.79 | $1.74 | $3.17 | $2.78 | $2.37 | $2.01 | $1.87 |
| shares | — | — | 80.43M | 82.47M | 83.07M | 83.62M | 85.2M | 85.34M | 86.12M | 86.86M | 87.77M | 89.73M | 92.6M | 100.09M | 106.32M | 54.99M | 56.79M | 57.71M | 58.81M | 59.95M |
| shares | — | — | 81.03M | 83.25M | 83.98M | 84.6M | 86.57M | 86.72M | 87.54M | 88.47M | 89.57M | 90.88M | 93.65M | 101.5M | 107.97M | 56.16M | 58.21M | 59.56M | 60.68M | 62.25M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $7.27B in buybacks.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of long-term debt | 2026-06-30 | USD 149,999,000 | 10-Q filed 2026-08-04 |
| Noncurrent debt carrying amount | 2026-06-30 | USD 299,865,000 | 10-Q filed 2026-08-04 |
| Operating lease liabilities | 2026-06-30 | USD 127,217,000 | 10-Q filed 2026-08-04 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
9.04×
Peer median 6.70×
EV/EBIT
28.22×
Peer median 34.51×
P/E (TTM)
36.49×
Peer median 35.23×
Peer medians compare against the 21 similar-size Diagnostics & Research companies (of 48 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Companion Animal Group Segment | $3,953,285,000 | $3,574,044,000 | $3,352,356,000 | $3,058,793,000 | $2,889,960,000 | $2,385,765,000 | $2,119,183,000 | $1,935,428,000 |
| Water Segment | $201,149,000 | $185,112,000 | $168,149,000 | $155,720,000 | $146,505,000 | $128,625,000 | $132,850,000 | $125,198,000 |
| Livestock and Poultry Diagnostics Segment | $131,787,000 | $122,060,000 | $121,659,000 | $122,607,000 | $135,887,000 | $145,845,000 | $132,635,000 | $130,581,000 |
| Other Segment | — | — | $18,789,000 | $30,204,000 | $43,008,000 | $46,420,000 | $22,240,000 | $22,035,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $2,752,785,000 | $2,533,174,000 | $2,391,427,000 | $2,182,959,000 | $1,995,683,000 | $1,691,224,000 | $1,495,516,000 | $1,357,909,000 |
| Europe the Middle East and Africa Other | $230,031,000 | $196,313,000 | $176,396,000 | $161,577,000 | $167,525,000 | $148,049,000 | $122,206,000 | $114,877,000 |
| Germany | $206,759,000 | $173,682,000 | $149,789,000 | $137,876,000 | $146,762,000 | $119,353,000 | $104,081,000 | $100,459,000 |
| Canada | $167,325,000 | $152,885,000 | $150,110,000 | $142,743,000 | $139,727,000 | $107,398,000 | $99,550,000 | $94,206,000 |
| United Kingdom | $154,435,000 | $134,630,000 | $121,745,000 | $110,400,000 | $114,955,000 | $90,156,000 | $90,969,000 | $87,807,000 |
| France | $126,003,000 | $110,795,000 | $96,797,000 | $84,479,000 | $90,836,000 | $74,814,000 | $64,767,000 | $60,319,000 |
| Asia Pacific Other | $124,364,000 | $110,104,000 | $104,107,000 | $96,291,000 | $89,523,000 | $68,206,000 | $61,055,000 | $56,868,000 |
| Australia | $112,247,000 | $101,959,000 | $95,465,000 | $96,408,000 | $94,414,000 | $79,629,000 | $71,069,000 | $63,386,000 |
| Latin America and Caribbean | $90,411,000 | $83,690,000 | $83,923,000 | $75,035,000 | $66,623,000 | $51,863,000 | $56,515,000 | $50,969,000 |
| Japan | $83,362,000 | $73,139,000 | $75,569,000 | $77,661,000 | $84,275,000 | $74,725,000 | $67,246,000 | $60,213,000 |
| Spain | $70,971,000 | $61,857,000 | $52,332,000 | $46,982,000 | $48,169,000 | $39,265,000 | $36,439,000 | $33,687,000 |
| Italy | $66,857,000 | $58,224,000 | $53,787,000 | $48,192,000 | $52,062,000 | $42,817,000 | $39,725,000 | $36,956,000 |
| Switzerland | $41,696,000 | $37,183,000 | $34,830,000 | $30,646,000 | $31,984,000 | $24,850,000 | $20,855,000 | $19,875,000 |
| Netherlands | $40,500,000 | $34,047,000 | $30,508,000 | $26,882,000 | $29,656,000 | $23,461,000 | $19,397,000 | $18,090,000 |
| China | $35,956,000 | $35,822,000 | $44,168,000 | $49,193,000 | $63,166,000 | $70,845,000 | $57,518,000 | $57,621,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Product | $2,539,210,000 | $2,248,178,000 | $2,089,936,000 | $1,928,773,000 | $1,875,308,000 | $1,586,809,000 | $1,423,144,000 | $1,322,683,000 |
| Service | $1,764,492,000 | $1,649,326,000 | $1,571,017,000 | $1,438,551,000 | $1,340,052,000 | $1,119,846,000 | $983,764,000 | $890,559,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|
| Companion Animal Group Segment | $1,012,740,000 | $800,949,000 | $824,022,000 | $574,887,000 | $462,605,000 | $412,623,000 | $363,557,000 |
| Water Segment | $74,340,000 | $72,519,000 | $65,444,000 | $58,867,000 | $61,923,000 | $56,639,000 | $50,616,000 |
| Livestock and Poultry Diagnostics Segment | $9,975,000 | $19,809,000 | $28,636,000 | $40,008,000 | $24,735,000 | $19,454,000 | $16,464,000 |
| Other Segment | $73,000 | $5,488,000 | $13,926,000 | $20,762,000 | $3,583,000 | $2,619,000 | $4,837,000 |
Operating Margin by Segment (%)
| Component | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Companion Animal Group Segment | 30.2% | 26.2% | 28.5% | 24.1% | 21.8% | 21.3% |
| Water Segment | 44.2% | 46.6% | 44.7% | 45.8% | 46.6% | 45.2% |
| Livestock and Poultry Diagnostics Segment | 8.2% | 16.2% | 21.1% | 27.4% | 18.6% | 14.9% |
| Other Segment | 0.4% | 18.2% | 32.4% | 44.7% | 16.1% | 11.9% |
Key facts
CIK
874716
CUSIP
45168D104
13F (30d)
24 filings
20 filers
Visit website
Investor relations